NCT02282904: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 3 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02282904 |
|---|---|
| Title | Haploidentical Transplant for Patients With Chronic Granulomatous Disease (CGD) Using Post-Transplant Cyclophosphamide |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Oct. 23, 2014 |
| Completion date | April 10, 2019 |
| Required reporting date | April 9, 2020, midnight |
| Actual reporting date | April 13, 2020 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 3 |